Dr. Katherine R. Antel, MD, PhD

Dr. Antel practices at MUSC University Hospital in Charleston, South Carolina.

Dr. Antel's NPI, 1518799022, was assigned on August 14, 2024. Dr. Antel holds South Carolina license 93169.

Dr. Antel's primary practice is MUSC University Hospital, at 171 Ashley Ave, Charleston, SC 29425 in Charleston County. The practice phone is (843) 792-1414.

Dr. Antel's primary practice is MUSC University Hospital in Charleston, South Carolina. Dr. Antel is also affiliated with MUSC Health University Medical Center. The medical group on file is MUSC Health. Dmand AI also links Dr. Antel to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Antel practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Antel's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Antel is licensed in South Carolina.

CMS data shows 50 Medicare services from Dr. Antel across 2 procedure codes in 2024, all of them office visits, for 61 Medicare patients. Medicare paid $4,550 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 61 Medicare patients who saw Dr. Antel in 2024. The largest group is 65 to 74, with 30 patients. 74% of them have high blood pressure, and 74% have high cholesterol. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Antel's median patient age at 68, with 45% women.

In 2024, Dr. Antel wrote 76 Medicare Part D claims for 22 patients. 80% of them were for generic drugs. CMS names the drug for 33 of them, across 2 drugs with 11 or more claims each, at $345 in total drug cost.

Dr. Antel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Antel as offering telehealth.

Dmand AI links 14 papers to Dr. Antel, published from 2015 to 2025. 2020 was the busiest year, with 5. The most frequent topics are HIV Infections, South Africa and Biopsy, Fine-Needle. Dr. Antel has published most often in Ann Hematol. Dr. Antel's most frequent co-authors are Philippe Armand, MD, PhD, Parastoo Bahrami Dahi, MD and Reid Weyant Merryman, MD.

CMS Open Payments shows 12 general payments to Dr. Antel from 4 drug and device companies in 2025. Travel and lodging make up the largest share, 66% of the total. Merck Sharp & Dohme Corporation paid the most, $1,314.